- 63.5k views
ER Management of Status Epilepticus in Children
Prompt and effective management of status epilepticus in children is critical to prevent neurological complications and long-term sequelae. Initial management involves ensuring the child's safety and stabilizing vital signs, followed by rapid administration of antiepileptic medications. Benzodiazepines such as lorazepam or midazolam are first-line agents for terminating seizures and preventing progression to status epilepticus. If seizures persist, second-line agents such as phenytoin, fosphenytoin, or levetiracetam may be administered intravenously to achieve seizure control. In refractory cases, continuous infusions of anesthetic agents such as midazolam or propofol may be initiated in the intensive care unit. Timely neuroimaging studies may be indicated to rule out structural abnormalities or identify potential reversible causes of status epilepticus.
About the Speaker

Dr. Col Om Prakash Singh
Professor & HOD Pediatrics Narayana Medical College, Patna
Dr. Om Prakash Singh is currently working as Professor & HOD Pediatrics in Narayana Medical College,Patna. He has 21 years of experience and 10+ yrs as Professor in Pediatrics. He has 27 publications across India. He is a life member of Indian Pediatric Association (IAP) & National Neonatal Forum ( NNF).
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.